CYP4Z2P
Putative inactive cytochrome P450 family member 4Z2
Also known as: CP4Z2_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for CYP4Z2P in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
340 residues, UniProt reviewed canonical sequence.
>Q8N1L4|CYP4Z2P
1 MEPSWLQELM AHPFLLLILL CMSLLLFQVI RLYQRRRWTI RAMHLFPAPP AHWFYGHKES
61 YPVKEFEVYP ELMEKYPCAV PLWVGPFTMF FNIHDPDYVK ILLKRQDPKS AVSHKILESW
121 VGRGLVTLDG SKWKKHRQIV KPGFNISILK IFITMMSKSV RMMLNKWEEH IAQNSRLELF
181 QHVSLMTLDS IMKCAFSHQG SIQLDSTLDS YLKAVFNLSK ISNQRMNNFL HHNDLVFKFS
241 SQGQIFSKFN QELHQFTEKV IQDRKESLKD KLKQDTTQKR RQDFLDILLS AKSENTKDFS
301 EADLQAEVKT FMFAGHDTTT TAISWIFYCL AKYPEHQQRCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CYP4Z2P can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.33
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
- heme binding
- iron ion binding
- monooxygenase activity
- oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CYP4Z2P as an antibody target. Whether an autoantibody or antibody against CYP4Z2P could matter depends on whether native CYP4Z2P is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CYP4Z2P is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CYP4Z2P as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...